MedPath

Flurbiprofen

Generic Name
Flurbiprofen
Drug Type
Small Molecule
Chemical Formula
C15H13FO2
CAS Number
5104-49-4
Unique Ingredient Identifier
5GRO578KLP
Background

Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.

Indication

Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis.

Associated Conditions
Ankylosing Spondylitis (AS), Back Pain, Acute, Chronic Back Pain, Menstrual Distress (Dysmenorrhea), Muscle Spasms, Non-Articular Rheumatic Muscle Spasms, Osteoarthritis (OA), Pain, Pain, Inflammatory, Post Traumatic Pain, Postoperative pain, Rheumatoid Arthritis, Spinal pain

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Phase 1
Completed
Conditions
Healthy Subjects
Infection, Human Immunodeficiency Virus
Interventions
First Posted Date
2009-06-15
Last Posted Date
2010-11-03
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
24
Registration Number
NCT00920088
Locations
🇺🇸

GSK Investigational Site, Baltimore, Maryland, United States

Flurbiprofen Tape for Treatment of Chronic Low Back Pain

Phase 2
Completed
Conditions
Chronic Low Back Pain
Interventions
Drug: Placebo Tape (Arm 1)
Drug: Placebo Tape (Arm 3)
First Posted Date
2008-09-25
Last Posted Date
2016-10-06
Lead Sponsor
Teikoku Pharma USA, Inc.
Target Recruit Count
127
Registration Number
NCT00759330
Locations
🇺🇸

Sarah Cannon Research Institute, Memphis, Tennessee, United States

🇺🇸

Internal Medicine Associates of Cordova, Cordova, Tennessee, United States

🇺🇸

Rainier Clinical Research Center, Inc., Renton, Washington, United States

and more 7 locations

Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2008-02-14
Last Posted Date
2017-09-11
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
23
Registration Number
NCT00615212
Locations
🇺🇸

GSK Investigational Site, Buffalo, New York, United States

Local Flurbiprofen to Treat Pain Following Wisdom Tooth Extraction

Phase 2
Completed
Conditions
Pain
First Posted Date
1999-11-04
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Target Recruit Count
100
Registration Number
NCT00001724
Locations
🇺🇸

National Institute of Dental And Craniofacial Research (NIDCR), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath